Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Comparison of Antibody Response Against SARS-CoV-2 in Hemodialysis and Non-dialysis Patients Diagnosed With COVID-19.

NCT04633915 is registered in ClinicalTrials.gov with Saint Petersburg State University, Russia as lead sponsor.

NCT NCT04633915
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04633915 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Comparison of Antibody Response Against SARS-CoV-2 in Hemodialysis and Non-dialysis Patients Diagnosed With COVID-19.
Lead sponsor
Saint Petersburg State University, Russia
Phase
Observational
Overall status
Completed
Start date
November 26, 2020
Completion date
July 18, 2021
Enrollment
51 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, dialysis